X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/theravance-biopharma-inc-to-host-virtual-key-opinion-leader-kol-event-to-discuss-ampreloxetines-potential-for-the-treatment-of-symptomatic-neurogenic-orthostatic-hypotension-noh-in-patients-with-multiple-system-atrophy-msa-302112659.html
https://www.prnewswire.com/news-releases/theravance-biopharma-inc-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-business-update-302071563.html
https://www.prnewswire.com/news-releases/theravance-biopharma-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-26-2024-302061365.html
https://www.prnewswire.com/news-releases/theravance-biopharma-announces-results-from-the-phase-4-yupelri-pifr-2-study-in-patients-with-severe-to-very-severe-chronic-obstructive-pulmonary-disease-copd-302026980.html
https://www.fiercepharma.com/pharma/beleaguered-theravance-logs-loss-head-head-copd-trial-against-boehringers-spiriva
https://www.prnewswire.com/news-releases/theravance-biopharma-to-present-new-ampreloxetine-data-at-the-34th-international-symposium-on-the-autonomic-nervous-system-301990170.html
https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-the-6th-annual-evercore-isi-healthconx-conference-301988516.html
https://www.prnewswire.com/news-releases/viatris-and-theravance-biopharma-announce-positive-top-line-results-from-yupelri-revefenacin-phase-iii-trial-in-china-for-the-treatment-of-chronic-obstructive-pulmonary-disease-copd-301985426.html
https://www.prnewswire.com/news-releases/theravance-biopharma-inc-reports-third-quarter-2023-financial-results-and-provides-business-update-301980723.html
https://www.prnewswire.com/news-releases/theravance-biopharma-to-report-third-quarter-2023-financial-results-on-november-7-2023-301961598.html
Market Place
Share 
